Seaport Therapeutics Surges 8.4% as 200‑Day SMA Breaks – New Upside Potential
Seaport Therapeutics surges past its 200‑day SMA, signaling potential upside ahead of clinical milestones and partnership announcements.
- SEAPORT THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read